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Research
Active cigarette smoking is the major cause 
of lung cancer and an important estab-
lished cause of cardiovascular disease (CVD) 
mortality (U.S. Department of Health and 
Human Services 2004, 2010). Risks have 
been shown to increase with even light or 
intermittent active smoking (Bjartveit and 
Tverdal 2005; Schane et al. 2010; U.S. 
Department of Health and Human Services 
2010). Secondhand smoke (SHS) is also an 
established cause of both lung cancer and 
CVD (U.S. Department of Health and 
Human Services 2004, 2006, 2010). Since 
the early 1990s, growing evidence has linked 
long-term exposure to fine particulate mat-
ter (particulate matter with an aerodynamic 
diameter ≤ 2.5 μm; PM2.5) air pollution with 
increases in the risk of cardiovascular mortal-
ity (Brook et al. 2010; Dockery et al. 1993; 
Krewski et al. 2009; Laden et al. 2006; Miller 
et al. 2007; Pope et al. 1995, 2004; Pope and 
Dockery 2006) and, to a lesser extent, lung 
cancer (Chen et al. 2008; Pope et al. 2002).
In a recent analysis, we evaluated the 
exposure–response relationship for cardio-
vascular mortality in relation to PM2.5 from 
active cigarette smoking, SHS, and ambient 
air pollution (Pope et al. 2009). The results 
suggested a relatively steep exposure–response 
function at very low levels of exposure and a 
flattening out of CVD risk at high exposure 
levels. Previous efforts to estimate the disease 
burden attributable to PM2.5 exposure have 
assumed that the adverse effects of PM2.5 on 
both cardiovascular and lung cancer mortal-
ity flatten out above 50 μg/m3 (Cohen et al. 
2004). If the lung cancer effects of PM2.5, 
however, do not flatten out at high levels of 
exposure similar to CVD, the estimates of the 
lung cancer excess disease burden from air pol-
lution would be substantially underestimated 
in areas with high levels of PM2.5 pollution.
In the present analysis, therefore, we 
explicitly conducted an original evaluation of 
the shape of the PM2.5-mortality exposure– 
response relationship for lung cancer. For 
direct comparison, we also reevaluated the 
shape of the PM2.5-mortality exposure– 
response relationship for CVD mortality using 
the same cohort, follow-up period, exclusion 
criteria, covariates, and related statistical mod-
eling approaches. In an integrative way, our 
approach evaluates exposure–  response rela-
tionships using three basic sources of exposure 
(active smoking, passive smoking, and ambi-
ent air pollution) in relation to two major 
health end points (cardiovascular and lung 
cancer mortality), using PM2.5 as the com-
mon index of exposure. There are limitations 
and uncertainties related to using any single 
measure as a common index of exposure. 
Nevertheless, this analysis allows for direct 
comparisons of the exposure–response rela-
tions for lung cancer versus CVD mortality 
and provides the opportunity to evaluate the 
implications of the observed differences when 
estimating the disease burden from PM2.5.
Methods
Cohort data. Estimates of adjusted relative 
risks (RRs) over different increments of active 
cigarette smoking are based on data collected 
by the American Cancer Society (ACS) as part 
of the Cancer Prevention Study II (CPS-II), 
an ongoing prospective cohort mortality study 
involving nearly 1.2 million adults. Ethics 
approval for the CPS-II was obtained from 
the Emory University School of Medicine 
Human Investigations Committee. More 
detailed descriptions of this cohort are pro-
vided elsewhere (Calle and Terrel 1993; Chao 
et al. 2000; Hoover et al. 2003; Krewski et al. 
2009; Pope et al. 2002). Participants from 
throughout the United States were enrolled by 
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Ba c k g r o u n d: Lung cancer and cardiovascular disease (CVD) mortality risks increase with 
  smoking, secondhand smoke (SHS), and exposure to fine particulate matter < 2.5 μm in diameter 
(PM2.5) from ambient air pollution. Recent research indicates that the exposure–response relation-
ship for CVD is non  linear, with a steep increase in risk at low exposures and flattening out at higher 
exposures. Comparable estimates of the exposure–response relationship for lung cancer are required 
for disease burden estimates and related public health policy assessments.
oBjectives: We compared exposure–response relationships of PM2.5 with lung cancer and cardio-
vascular mortality and considered the implications of the observed differences for efforts to estimate 
the disease burden of PM2.5.
Me t h o d s : Prospective cohort data for 1.2 million adults were collected by the American Cancer 
Society as part of the Cancer Prevention Study II. We estimated relative risks (RRs) for increments 
of cigarette smoking, adjusting for various individual risk factors. RRs were plotted against esti-
mated daily dose of PM2.5 from smoking along with comparison estimates for ambient air pollution 
and SHS.
re s u l t s: For lung cancer mortality, excess risk rose nearly linearly, reaching maximum RRs > 40 
among long-term heavy smokers. Excess risks for CVD mortality increased steeply at low exposure 
levels and leveled off at higher exposures, reaching RRs of approximately 2–3 for cigarette smoking.
co n c l u s i o n s: The exposure–response relationship associated with PM2.5 is qualitatively different 
for lung cancer versus cardiovascular mortality. At low exposure levels, cardiovascular deaths are 
projected to account for most of the burden of disease, whereas at high levels of PM2.5, lung cancer 
becomes proportionately more important.
key w o r d s : air pollution, cardiovascular disease, lung cancer, mortality, particulate matter, smok-
ing. Environ Health Perspect 119:1616–1621 (2011).  http://dx.doi.org/10.1289/ehp.1103639 
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> 77,000 volunteers between September 1982 
and February 1983. Enrollment was restricted 
to persons who were ≥ 30 years of age and who 
were members of households with one or more 
members ≥ 45 years of age. At enrollment, 
participants completed a self-administered con-
fidential questionnaire that captured data on a 
range of demographic, lifestyle, medical, and 
other individual charac  teristics (ACS 2011). 
Through 1988, vital status of study partici-
pants was ascertained by both personal contact 
and subsequently through linkage with the 
National Death Index (Calle and Terrel 1993). 
Death certificates were obtained and coded for 
cause of death.
Cause of death was coded according to 
two-digit ACS codes that were consolidations 
of International Classification of Diseases, 9th 
Revision (ICD-9) codes (Pope et al. 2004; 
World Health Organization 1977). Lung 
cancer deaths included deaths due to malig-
nant neoplasms of the trachea, bronchus, and 
lung (ICD-9 162). As discussed elsewhere 
(Pope et al. 2009), cardiovascular diseases and 
cardio  pulmonary diseases (CPDs) have sub-
stantial common comorbidity. Cross-coding 
and misclassification of primary causes of 
death are inherent in the use of death cer-
tificate data, making it unclear which ICD-9 
groupings most generally or specifically indi-
cate death due to CVD. For example, inflam-
mation associated with pulmonary disease 
contributes to cardiovascular risk (van Eeden 
et al. 2005), and individuals with chronic 
obstructive pulmonary disease are likely to be 
coded as dying of CVD based on death certifi-
cate data (Sin et al. 2005; Speizer et al. 1989). 
Because of this cross-classification problem, 
we examined the exposure–response function 
for CVD deaths using three different outcome 
groupings, namely, a) ischemic heart disease 
(IHD) (ICD-9 410–414), b) CVD (ICD-9 
401–459), and c) CPD (ICD-9 401–459 and 
460–519).
Because additional information regard-
ing cigarette smoking was not collected after 
enrollment, the present analysis was based on 
a restricted follow-up period of approximately 
6 years through 31 December 1988. The 
unrestricted CPS-II cohort included a total of 
1,184,881 participants. For this analysis, sub-
jects were excluded if they had prevalent cancer 
(except non  melanoma skin cancer) at baseline 
(82,329), or if they had missing or erroneous 
data for vital status (419), race (5,318), edu-
cation (16,946), marital status (5,239), body 
mass index (30,291), SHS exposure (9,799), or 
cigarette smoking habits or history (208,835). 
Because this study is focused on effects of long-
term exposure, we also excluded participants 
who started smoking after 25 years of age 
(30,921). The final analytic cohort included 
794,784 subjects, among whom 3,194 lung 
cancer deaths, 11,607 IHD deaths, 19,290 
cardiovascular deaths, and 22,021 cardio-
pulmonary deaths occurred during the approxi-
mately 6-year follow-up period.
Statistical analysis. Cox proportional haz-
ards survival models (Fleming and Harrington 
1991) were estimated separately for lung can-
cer, ischemic heart, cardiovascular, and cardio-
pulmonary deaths. Data from participants who 
died of other causes were censored at time of 
death. Survival time from the date of enroll-
ment was used as the time axis. Baseline haz-
ard functions were stratified by 1-year age 
categories, sex, and race (white, black, other). 
The models included indicator variables for 
smoking increments of ≤ 3, 4–7, 8–12, 13–17, 
18–22, 23–27, 28–32, 33–37, 38–42, and 
≥ 43 cigarettes per day for current smokers 
relative to never smokers. To control for smok-
ing in previous smokers relative to never smok-
ers, former-smoking indicator variables using 
the same cigarettes-per-day increments were 
included in the models. Additionally, the mod-
els included variables to control for education 
(two variables that indicate high school edu-
cation or more than high school education 
versus less than high school education), marital 
status (two variables that indicate separated/
divorced/widowed or single versus married), 
body mass (two variables representing linear 
and squared terms for body mass index), alco-
hol consumption (six variables that indicate 
consumption of or missed reporting of beer, 
wine, or other alcohol versus non  drinkers), 
occupational exposures [one variable indicating 
self-reported exposure to dust and fumes in the 
workplace and seven additional variables that 
indicate different rankings of an occupational 
dirtiness index versus a referent category, as 
has been developed and described elsewhere 
(Siemiatycki et al. 2003)], and diet [eight 
indicator variables that contrasted quintiles of 
dietary fat consumption and quintiles of com-
bined consumption of vegetables, citrus, and 
high-fiber grains (Chao et al. 2000)].
To evaluate potential effect modification 
by sex, we also modeled the Cox proportional 
hazards estimates described above separately 
for males and females. To account for the 
impact of smoking duration on effect esti-
mates and the shape of the exposure–response 
relationship, we conducted further analyses 
that stratified all of the cigarettes-per-day 
smoking increments by three levels of smok-
ing duration. Specifically, the cigarettes-per-
day smoking increment indicator variables 
(for current and previous smokers) were each 
replaced by three variables that indicated the 
specific cigarettes-per-day increments for three 
smoking durations: < 30 years, 30–39 years, 
and ≥ 40 years.
Plotting exposure–response relationships. 
The adjusted RRs (as estimated by the haz-
ard ratios from the Cox proportional hazard 
model) associated with different increments 
of PM2.5 exposure from active cigarette smok-
ing, SHS, and ambient air pollution were 
plotted against estimated average daily inhaled 
dose of PM2.5. For active smoking, the aver-
age inhaled dose was assumed to be 12 mg 
PM2.5 per cigarette. The actual amount of 
PM2.5 inhaled per cigarette is influenced 
more by individual inhalation and smoking 
patterns than by the tar level measured by 
machine smoking (National Cancer Institute 
2001). Nevertheless, the estimated sales-
weighted average of PM from cigarettes sold 
in the United States in the 1980s and 1990s 
was approximately 12–14 mg per cigarette 
(National Cancer Institute 2001). Because 
of uncertainty regarding estimates of PM2.5 
exposure per cigarette smoked, reference expo-
sure scaling expressed as actual increments of 
cigarettes smoked per day is also provided in 
the exposure–response plots.
Comparative estimates of excess risk of 
mortality from long-term exposure to ambi-
ent air pollution come from several key pro-
spective cohort studies, including estimates 
from analyses using ACS CPS-II cohort 
participants who lived in metropolitan areas 
with available air pollution data (Pope et al. 
1995, 2002, 2004), analyses of the Harvard 
Six Cities (HSC) study (Dockery et al. 
1993; Laden et al. 2006), and the Women’s 
Health Initiative (WHI) study (Miller et al. 
2007). The RRs of mortality are taken from 
the published estimates from these studies. 
The average daily dose of inhaled PM2.5 is 
estimated by multiplying the relevant aver-
age ambient PM2.5 concentrations by average 
daily inhalation rates (cubic meters per day). 
Actual ventilation rates depend on age, sex, 
body size, activity levels, and other factors. 
The estimated average volume of air inhaled 
daily by adults ranges from 13 to 23 m3/day 
(Allan et al. 2008; Brochu et al. 2006; Layton 
1993; Stifelman 2007; U.S. Environmental 
Protection Agency 1997). Our analyses use 
18 m3/day (Allan et al. 2008; Brochu et al. 
2006; Stifelman 2007) in calculating PM2.5 
dosage at various levels of air pollution. Based 
on the key prospective cohort studies cited 
above, the range of average ambient PM2.5 
concentrations is approximately 5–30 μg/m3, 
resulting in estimated daily dose of PM2.5 
from ambient air pollution potentially rang-
ing from 0.09 to 0.54 mg. In our analyses, 
however, the plotted RRs represent changes in 
risk across contrasts in exposure that are inter-
nal to and reported by the specific studies.
Comparative estimates of excess risk of 
mortality from long-term exposure to SHS 
come from pooled estimates from the 2006 
Surgeon General’s Report (SGR) (U.S. 
Department of Health and Human Services 
2006). These pooled estimates include expo-
sure assessments based simply on SHS exposure 
at home or work (for example, non  smokers Pope et al.
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living with a spouse who smokes or nonsmok-
ers employed in an SHS environment) and 
on more quantified assessment of SHS expo-
sure including low to moderate SHS exposure 
(passive exposure to either 1–14 or 1–19 ciga-
rettes per day) and moderate to high exposure 
(≥ 15 or ≥ 20 cigarettes per day). Additionally, 
risk estimates for acute myocardial infarction 
from the INTERHEART study (Teo et al. 
2006) of 52 countries associated with 1–7 hr 
per week of SHS exposure or exposure from 
living with a spouse who smoked are included. 
Estimated average PM2.5 exposure is approxi-
mately 20 μg/m3 for low to moderate SHS 
exposure and exposure incurred over an inter-
val of 1–7 hr per week, 50 μg/m3 for moderate 
to high exposure, 30 μg/m3 for living with a 
spouse who smokes, and 40 μg/m3 for working 
in a workplace with reported SHS exposure. 
These estimates are based on limited data from 
studies that sampled the PM2.5 concentra-
tions from SHS in various settings over time 
(Dockery and Spengler 1985; Jenkins et al. 
1996; Leaderer and Hammond 1991; Spengler 
1991; Spengler et al. 1985; U.S. Department 
of Health and Human Services 2006). The 
average daily dose of inhaled PM2.5 from SHS 
is estimated by multiplying the estimated aver-
age concentrations by the inhalation rate of 
18 m3/day.
To help illustrate the integrated expo-
sure–response relationship, the risk and dose 
estimates for different increments of active 
smoking, SHS, and ambient PM2.5 were used 
to fit a simple power function of the form 
[RR = 1 + α(dose)β] for both lung cancer and 
cardiovascular mortality. This functional form 
was selected because it represents a simple, 
well-behaved, non  linear, monotonic func-
tion that goes through the origin (RR = 1 at 
a dose of zero). The functions were fit using 
iterative non  linear regression (PROC NLIN 
in SAS, release 9.2; SAS Institute Inc., Cary, 
NC, USA) and were plotted along with the 
specific point estimates.
Results
Table 1 presents selected summary statistics 
for the primary ACS CPS-II analytic cohort 
used to estimate the adjusted RRs for different 
increments of cigarette smoking. Table 2 pres-
ents adjusted RRs and estimated daily dose 
of PM2.5 for various increments of exposure 
from cigarette smoking, SHS, and ambient 
air pollution from the present analysis and the 
selected comparison studies. Figure 1A pres-
ents the adjusted RR estimates for lung cancer 
mortality plotted against estimated daily dose 
of PM2.5 from different increments of current 
cigarette smoking (relative to never smokers) 
and from different exposures from ambient 
air pollution and SHS. Figure 1B presents 
the adjusted RRs for IHD, CVD, and CPD 
plotted against estimated daily dose of PM2.5 
from different increments of current cigarette 
smoking (relative to never smokers) and from 
different exposures from ambient air pollu-
tion and SHS. Because the estimated doses 
from different increments of active smoking 
are dramatically larger than estimated doses 
from ambient air pollution or SHS, associa-
tions at lower exposure levels (due to ambient 
air pollution and SHS) are shown as insets 
with a magnified scale. The comparative 
mortality risk estimates for PM2.5 and SHS 
represent changes in risk across contrasts in 
exposure that are internal to the specific or 
pooled studies.
Table 1. Selected summary statistics for the ACS 
analytic cohort.
Characteristic
Summary 
statistic
Total subjects in analytic cohort (n) 794,784
Age at enrollment [years (mean ± SD)] 56.0 ± 10.5
Body mass index (mean ± SD) 25.1 ± 4.0
Percentage of cohort
Female 61.0
White 94.3
High school education 33.1
> High school education 53.7
Current smoker 19.9
Former smoker 26.8
Percentage of current smokers who smoked
≤ 3 cigarettes/day 3.7
4–7 cigarettes/day 5.8
8–12 cigarettes/day 12.2
13–17 cigarettes/day 7.2
18–22 cigarettes/day 33.4
23–27 cigarettes/day 5.0
28–32 cigarettes/day 13.9
33–37 cigarettes/day 1.6
38–42 cigarettes/day 13.3
≥ 43 cigarettes/day 3.9
Percentage of current smokers with smoking duration
< 30 years 31.2
30–39 years 38.8
≥ 40 years 30.0
Table 2. Adjusted RR estimatesa for various increments of exposure from cigarette smoking (versus never smokers), SHS, and ambient air pollution from the 
present analysis and selected comparison studies.
Adjusted RR (95% confidence interval) Estimated daily 
dose PM2.5 (mg)b Source of risk estimate Increments of exposure Lung cancer IHD CVD CPD
ACS-present analysis ≤ 3 (1.5) cigarettes/day 10.44 (7.30, 14.94) 1.61 (1.27, 2.03) 1.58 (1.32, 1.89) 1.72 (1.46, 2.03) 18
ACS-present analysis 4–7 (5.5) cigarettes/day 8.03 (5.89, 10.96) 1.64 (1.37, 1.96) 1.73 (1.51, 1.97) 1.84 (1.63, 2.08) 66
ACS-present analysis 8–12 (10) cigarettes/day 11.63 (9.51, 14.24) 2.07 (1.84, 2.31) 2.01 (1.84, 2.19) 2.10 (1.94, 2.28) 120
ACS-present analysis 13–17 (15) cigarettes/day 13.93 (11.04, 17.58) 2.18 (1.89, 2.52) 1.99 (1.77, 2.23) 2.08 (1.87, 2.32) 180
ACS-present analysis 18–22 (20) cigarettes/day 19.88 (17.14, 23.06) 2.36 (2.19, 2.55) 2.42 (2.28, 2.56) 2.52 (2.39, 2.66) 240
ACS-present analysis 23–27 (25) cigarettes/day 23.82 (18.80, 30.18) 2.29 (1.91, 2.75) 2.33 (2.02, 2.69) 2.33 (2.03, 2.67) 300
ACS-present analysis 28–32 (30) cigarettes/day 26.82 (22.54, 31.91) 2.22 (1.97, 2.49) 2.17 (1.98, 2.38) 2.39 (2.19, 2.60) 360
ACS-present analysis 33–37 (35) cigarettes/day 26.72 (18.58, 38.44) 2.58 (1.91, 3.47) 2.52 (1.98, 3.19) 2.83 (2.28, 3.52) 420
ACS-present analysis 38–42 (40) cigarettes/day 30.63 (25.79, 36.38) 2.30 (2.05, 2.59) 2.37 (2.16, 2.59) 2.61 (2.40, 2.84) 480
ACS-present analysis ≥ 43 (45) cigarettes/day 39.16 (31.13, 49.26) 2.00 (1.62, 2.48) 2.17 (1.84, 2.56) 2.37 (2.04, 2.76) 540
ACS-air pol original 24.5 μg/m3 ambient PM2.5 — — — 1.31 (1.17, 1.46) 0.44
ACS-air pol extend 10 μg/m3 ambient PM2.5 1.14 (1.04, 1.23) 1.18 (1.14, 1.23) 1.12 (1.08, 1.15) 1.09 (1.03, 1.16) 0.18
HSC-air pol original 18.6 μg/m3 ambient PM2.5 — — — 1.37 (1.11, 1.68) 0.33
HSC-air pol extend 10 μg/m3 ambient PM2.5 1.21 (0.92, 1.69) — 1.28 (1.13, 1.44) — 0.18
WHI-air pol 10 μg/m3 ambient PM2.5 — — 1.24 (1.09, 1.41)c — 0.18
SGR-SHS Low–moderate SHS exposure — — 1.16 (1.03, 1.32) — 0.36
SGR-SHS Moderate–high SHS exposure — — 1.26 (1.12, 1.42) — 0.90
SGR-SHS Live with smoking spouse 1.21 (1.13, 1.30) — — — 0.54
SGR-SHS Work with SHS exposure 1.22 (1.13, 1.33) — — — 0.72
INTERHEART 1–7 hr/week SHS exposure — 1.24 (1.17, 1.32)d — — 0.36
INTERHEART Live with smoking spouse — 1.28 (1.12, 1.47)d — — 0.54
Study name abbreviations: ACS-present analysis, the present analysis of the ACS CPS-II cohort; ACS-air pol original, the original analysis of air pollution and mortality using the ACS 
CPS-II cohort (Pope et al. 1995); ACS-extend, extended analyses of air pollution and mortality using the ACS CPS-II cohort (Pope et al. 2002 and 2004); HSC-air pol original, the original 
analysis of air pollution and mortality using the HSC cohort (Dockery et al. 1993); HSC-air pol extend, an extended analysis of air pollution and mortality using the HSC cohort (Laden 
et al. 2006); WHI-air pol, an analysis of air pollution and fatal and non-fatal cardiovascular events using the WHI cohort (Miller et al. 2007); SGR-SHS, SGR that provides pooled esti-
mates for SHS (U.S. Department of Health and Human Services 2006); INTERHEART, a 52-country case–control study of tobacco use and risk of myocardial infarction (Teo et al. 2006).
aAdjusted RR estimates are for mortality unless otherwise noted. bThe estimated daily dose assumes an inhalation rate of 18 m3/day and a dose of 12 mg/cigarette. cFirst CVD event. 
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The dotted lines in Figure 1A and B rep-
resent the fitted nonlinear power function. 
For lung cancer, the fitted function [RR = 1 
+ 0.3195(dose)0.7433] represents a monotonic, 
nearly linear exposure–response relationship 
with fairly constant marginal increases in 
RR with increasing exposure. As reported in 
Table 2 and as can be seen in Figure 1, the 
adjusted RR of lung cancer rises with increased 
exposure throughout the full observed range 
of exposure. For CVD (and related cause-of-
death groupings) the fitted function [RR = 1 
+ 0.2685(dose)0.2730] indicates an exposure–
response relationship that is substantially non-
linear, that is, much steeper at the very low 
levels of exposure compared with higher levels 
of exposure. At very low levels of exposure—
within the range of exposures associated with 
ambient air pollution and SHS—excess mor-
tality risks are similar for lung cancer and CVD 
mortality (compare the rescaled inserts in 
Figure 1). For lung cancer mortality, the RRs 
steadily increase to nearly 40 at the highest 
increment of cigarette smoking (> 42 cigarettes 
per day), whereas for CVD mortality, the RRs 
level off at approximately 2.0–2.5.
A similar, near-linear exposure–response 
function for lung cancer mortality was observed 
for both men and women when adjusted risk 
ratios were stratified by sex (results not shown). 
For CVD mortality, the adjusted RRs associ-
ated with smoking ≤ 3 cigarettes per day were 
notably lower for women than for men, but at 
higher levels of smoking (≥ 18–22 cigarettes/
day), the adjusted RRs were somewhat higher 
for women than for men. However, for both 
men and women, the excess risk for CVD mor-
tality tended to level off at high exposures.
Models that also accounted for differ-
ent strata of smoking duration (< 30 years, 
30–39 years, or ≥ 40 years) did not indicate 
consistent differences in the exposure–response 
relationship for CVD mortality, and non-
linear exposure–response relationships for all 
three smoking-duration strata were consistent 
with the exposure–response relationship for 
the population as a whole (data not shown). 
Exposure–response curves for lung cancer 
mortality were nearly linear for all strata of 
smoking duration, consistent with results for 
the population as a whole, but the slopes var-
ied by smoking duration, with the exposure–
response function much less steep for those 
with a smoking duration of < 30 years. Our 
ability to evaluate effects of smoking dura-
tion independent of age was limited by design, 
because this analytic cohort was constrained 
to smokers who started smoking as teenagers 
or young adults, and smoking duration was 
therefore highly correlated with age (correla-
tion coefficient 0.83).
Discussion
Results for CVD mortality were consistent 
with those from a previous analysis (Pope 
et al. 2009). Specifically, the exposure– 
response function is relatively steep at very 
low levels of exposure (in the range associated 
with exposure to SHS and ambient air pollu-
tion) and flattens out at high exposure levels 
(consistent with exposure from active cigarette 
smoking). Results from recent studies that 
have found surprisingly sizable reductions in 
acute cardiovascular events after public bans 
on smoking (Institute of Medicine 2010) are 
qualitatively consistent with our findings.
In the present analysis, we further evalu-
ated the PM2.5 exposure–response relation-
ship for lung cancer mortality and contrasted it 
with comparably estimated exposure–response 
relationships for cardiovascular mortality using 
the same cohort, follow-up period, statistical 
models, and adjustment for other risk factors. 
The exposure–response function for PM2.5 and 
lung cancer mortality is different than that for 
cardiovascular mortality in two important ways. 
First, the basic shapes of the exposure–response 
functions differ. For lung cancer mortality, 
excess risks rise nearly linearly throughout the 
full range of exposure from SHS, air pollution, 
and active smoking, reaching maximum RRs 
> 40 for heavy smokers.
Second, smoking duration appeared to 
have a much larger impact on lung cancer 
mortality than on CVD mortality. A more 
complete discussion of how CVD mortality 
risk is affected by the duration and inten-
sity of exposure, provided elsewhere (Pope 
et al. 2011), suggests that most of the car-
diovascular effects are associated with expo-
sure most proximal in time and over exposure 
duration windows of a few years to approxi-
mately a decade. Consistent with these find-
ings, stratifying by exposure durations of 
< 30 years, 30–39 years, or ≥ 40 years did 
not result in substantially different exposure–
response relationships for CVD mortality 
risk, in contrast with our findings for lung 
cancer mortality. The importance of dura-
tion of smoking for lung cancer was estab-
lished in the British Doctor’s Study (Doll and 
Peto 1978) and has been confirmed by more 
complete analyses of age, duration of smok-
ing, and daily cigarette consumption based 
Figure 1. Adjusted RRs [with 95% confidence intervals (CIs)] of lung cancer mortality (A) and IHD, cardiovascular, and cardiopulmonary mortality (B) plotted over 
estimated daily exposure of PM2.5 (milligrams) and increments of cigarette smoking relative to never smokers (cigarettes/day). Diamonds represent comparative 
mortality risk estimates (with 95% CIs) for PM2.5 from air pollution from the comparative studies (Dockery et al. 1993; Laden et al. 2006; Miller et al. 2007; Pope et al 
1995, 2002, 2004). Stars represent comparable pooled RR estimates (with 95% CIs) associated with SHS exposure from comparative studies (Teo et al. 2006; U.S. 
Department of Health and Human Services 2006). The dotted lines represent the non  linear power function fit through the origin and the estimates (including active 
smoking, SHS, ambient PM2.5). Estimated doses from different increments of active smoking are dramatically larger than estimated doses from ambient air pollu-
tion or SHS; therefore, associations at lower exposure levels (due to ambient air pollution and SHS) are shown as insets with a magnified scale. 
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on the ACS CPS-II cohort (Flanders et al. 
2003; Thun et al. 1997) and case–control 
studies of residential radon and lung cancer 
(Lubin et al. 2007). In the present analysis, 
we integrated exposure and risk information 
for active smoking, passive cigarette smoking, 
and air pollution to evaluate the shape of the 
exposure–response relationship. The range of 
duration of active smoking was constrained 
by design to facilitate comparisons with stud-
ies of long-term exposure to air pollution and 
SHS. Strong correlations between age and 
exposure duration, the fact that the Cox pro-
portional hazards models strictly controlled 
for age (by allowing separate baseline hazards 
for each age, sex, race strata), and changes in 
baseline mortality risk with aging limit our 
ability to evaluate effects of exposure duration 
separately from effects of age. Nevertheless, 
these results clearly demonstrate fundamen-
tal differences in the shapes of the exposure–
response functions for lung cancer mortality 
versus cardiovascular mortality.
The exposure–response relationship for 
PM2.5 and lung cancer mortality appears to 
be nearly linear. These results are consistent 
with previous analyses that demonstrated that 
lung cancer mortality risk estimates for SHS 
are similar to risk estimates calculated indirectly 
from linear extrapolations of excess risk from 
active smokers (Hackshaw et al. 1997). The dif-
ferences in the exposure–response relationships 
for lung cancer versus CVD may have mecha-
nistic implications, because the pathogenicity 
of PM2.5 for cardiovascular end points may 
be mediated more by the particles themselves, 
whereas the lung cancer hazard is thought to be 
mediated largely by carcinogenic compounds 
carried on the particles. Carcinogens found 
in tobacco smoke and in combustion-source 
air pollution are the likely agents responsible 
for the excess lung cancer risk. Fine particles 
transport many of the toxic and carcinogenic 
substances in smoke and may contribute to pul-
monary and systemic inflammation. Chronic 
inflammation may promote genetic and possi-
bly epigenetic changes that transform a normal 
cell through a multistep process toward malig-
nancy. More complete reviews and discussions 
regarding the mechanistic pathways that par-
ticulate exposure can contribute to lung cancer 
and CVD are provided elsewhere (Brook et al. 
2010; U.S. Department of Health and Human 
Services 2010).
There are at least four possible explanations 
for the very steep exposure–response for CVD 
mortality at low levels of exposure (within the 
ranges associated with air pollution and SHS) 
and the leveling off at high exposures (for active 
cigarette smoking): a) systematic scaling distor-
tions, b) differential toxicities, c) self-selected 
smokers who are less susceptible to cardiovas-
cular effects, and d) the occurrence of a satu-
ration phenomenon with relatively low levels 
of exposure capable of activating relevant bio-
logical pathways. Use of the estimated average 
daily inhaled dose of PM2.5 as the common 
exposure metric to plot the exposure–response 
relationship as well as the potential for system-
atic measurement error in PM2.5 exposure esti-
mates could result in scaling distortions. For 
example, information on cigarette smoking and 
residence history was not collected after enroll-
ment in the ACS cohort. Changes in smoking 
habits, including quitting smoking, may result 
in underestimation of effects, although this bias 
would likely be minimal over the short 6-year 
follow-up. Furthermore, changes in cigarette 
design and compensatory smoking behavior 
may have changed the inhaled dose of PM2.5 
per cigarette. Changes in assumptions used to 
calculate doses (such as ventilation rates, yields 
of PM2.5 per cigarette, and estimates of aver-
age concentrations from SHS) would alter the 
exposure estimates and dose scaling presented in 
Figure 1. Although it is possible that systematic 
scaling issues would fundamentally influence 
the shape of the exposure–response relation-
ship, we used the same exposure scaling for 
lung cancer and cardiovascular mortality, and 
the fact that the lung cancer exposure–response 
was nearly linear suggests that the exposure scal-
ing may be reasonable. For lung cancer, the pri-
mary anomaly was the relatively high adjusted 
RR (approximately 10) estimated for very light 
smokers (≤ 3 cigarettes/day).
The shape of the CVD mortality exposure–
response relationship might also reflect varia-
tion in biological mechanisms, characteristics of 
exposure, and the toxicity of PM2.5 depending 
on the composition of fine particles from dif-
ferent sources—from active smoking, SHS, or 
air pollution. Components or combinations 
of components of fine particulates from cig-
arette smoke and other combustion sources, 
as well as the mechanisms responsible for the 
observed adverse cardiovascular health effects, 
have yet to be fully elucidated. However, the 
differential toxicity explanation is not fully 
consistent with the fact that in the range of 
exposures associated with active smoking alone 
the exposure–  response curve is remarkably 
flat and, if extrapolated back to zero, would 
not go through the origin. Assuming there is 
no excess risk at zero exposure (i.e., that the 
dose–response curve should go through the 
origin in the absence of exposure), a monotonic 
exposure–response function based only on the 
evidence of excess risk due to active smok-
ing would require a non  linear function that is 
steeper at low exposures and flattens out at high 
exposures. This explanation could be tested fur-
ther in future analyses that include estimates of 
cardiovascular mortality associated with expo-
sures to high concentrations of fine particles 
from diverse combustion and non  combustion 
sources. Studies of occupational groups, such as 
underground miners exposed to diesel exhaust 
and women exposed to high levels of PM from 
household fuel combustion, both coal and bio-
mass, could potentially   provide such estimates.
The third potential explanation for the lev-
eling off of the exposure–response relationship 
for CVD mortality in the range of exposures 
from active smoking is that individuals who 
are less susceptible to adverse cardio  pulmonary 
effects of smoking may be more likely to 
smoke and continue smoking than those who 
are more susceptible. Exposure to ambient 
air pollution (and SHS, to a lesser degree) is 
largely involuntary and therefore is not likely 
to be biased by self-selection. This explanation 
implies that in the absence of self-selection, the 
relative effects of high exposures from active 
smoking would be larger than estimated in 
this analysis. However, this explanation also 
assumes that self-selection would not be rele-
vant to lung cancer susceptibility. In addition, 
similar to the discussion of differential toxicity 
above, this explanation is not fully consistent 
with the fact that in the range of exposure 
due to active smoking alone, the exposure–
response function is remarkably flat.
The fourth potential explanation regarding 
the steep exposure–response for CVD mortal-
ity at low levels of exposure and the leveling 
off at high exposures is a saturation phenom-
enon whereby relatively low levels of exposure 
are capable of activating relevant biological 
pathways. There is substantial and growing 
evidence that long-term exposures to PM2.5 
from cigarette smoke, ambient air pollution, 
or both affect multiple physiologic pathways. 
Even low levels of exposure from SHS and 
ambient air pollution have been associated 
with pulmonary and systemic oxidative stress, 
inflammatory vascular dysfunction, increased 
platelet activation and blood viscosity, athero-
sclerosis, IHD, and altered cardiac autonomic 
function (Ambrose and Barua 2004; Brook 
et al. 2010; Pope et al. 2004; U.S. Department 
of Health and Human Services 2006, 2010). 
An evaluation of the pathophysiology of ciga-
rette smoke and CVD suggests that underlying 
biochemical and cellular processes may become 
saturated with small doses of toxic components 
(Ambrose and Barua 2004). A recent study, 
for example, reported small airway epithelium 
responses (transcriptome modifications) to even 
the lowest levels of cigarette smoke exposures 
(Strulovici-Barel et al. 2010). There is evidence 
that relevant biological pathways for CVD may 
be activated at low levels of exposure and that 
increasing exposure further increases risk, but 
at a decreasing marginal rate.
The empirical findings of this analysis have 
important public health implications (Smith 
and Peel 2010). Better quantification of the 
exposure–response gradients across environ-
mentally relevant ranges of exposure helps 
inform public health policy decisions. Estimates 
of the burden of disease attributable to air Air pollution, cigarette smoke, CVD, and lung cancer
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pollution are sensitive to assumptions regarding 
the shape of the exposure–response relation-
ship, but most of the studies of the effects on 
cardiovascular mortality of long-term exposure 
to PM2.5 have been conducted in areas where 
annual average concentrations range between 
approximately 5 and 35 μg/m3. Average con-
centrations of particulate air pollution in major 
population centers of China, India, and other 
developing countries are often much higher, 
exceeding 100 μg/m3 according to recent esti-
mates (Sivertsen 2006; van Donkelaar et al. 
2010). For CVD, inappropriate extrapolations 
of linear exposure–response functions may 
result in substantial overestimates in areas with 
very high exposures and, in some cases, poten-
tial underestimates in areas with relatively low 
exposures. These results confirm our previous 
finding (Pope et al. 2009) that, for CVD, the 
exposure–response relationship is non  linear, 
with a steep increase in risk at low exposures 
and flattening out at higher exposures. These 
results, however, indicate a substantively dif-
ferent exposure–response relationship for lung 
cancer mortality and suggest that it may be 
reasonable to assume a near linear exposure–
response function when estimating burdens of 
disease across a wide range of exposures.
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